Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

An Effect of Letrozole on Gastric Cancer?

  • Hadi, Ahmed E.L. (Department of General Surgery, Aneurin Bevan Healthcare NHS Trust Nevill Hall Hospital) ;
  • Al-Momani, Hazem (Department of General Surgery, Aneurin Bevan Healthcare NHS Trust Nevill Hall Hospital) ;
  • Edwards, Paul (Department of General Surgery, Aneurin Bevan Healthcare NHS Trust Nevill Hall Hospital)
  • Received : 2011.06.29
  • Accepted : 2011.09.15
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Letrozole is a drug used in the treatment of postmenopausal women with breast and ovarian tumours. There is no evidence in the literature indicating its use in treating gastric cancer. We present a 68 year old lady admitted from the emergency department with weight loss, malaise and anaemia. Investigations confirmed the presence of two different primary tumours in the left breast and the stomach. Following that this patient with oestrogen receptor positive breast cancer and oestrogen receptor negative gastric cancer was treated with letrozole for her breast cancer followed by a gastric resection. Independent histology by two pathologists pre-operatively diagnosed gastric adenocarcinoma. Post-operatively, independent analysis of the resected stomach, omentum and lymph nodes revealed no evidence of gastric cancer. Therefore we conclude that there is a possibility of letrozole having an effect on gastric cancer. Further studies are needed.

Keywords

References

  1. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-282. https://doi.org/10.1056/NEJMra050776
  2. Bhatnagar AS. Th e discovery and mechanism of action of letrozole. Breast Cancer Res Treat 2007;105(Suppl 1):7-17.
  3. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-1802. https://doi.org/10.1056/NEJMoa032312
  4. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated fi ndings from NCIC CTG MA.17. J Natl Cancer Inst 2005;97:1262-1271. https://doi.org/10.1093/jnci/dji250
  5. Tremblay F, Jamison B, Meterissian S. Breast cancer masquerading as a primary gastric carcinoma. J Gastrointest Surg 2002;6:614-616. https://doi.org/10.1016/S1091-255X(01)00006-3
  6. Yim H, Jin YM, Shim C, Park HB. Gastric metastasis of mammary signet ring cell carcinoma--a diff erential diagnosis with primary gastric signet ring cell carcinoma. J Korean Med Sci 1997;12:256-261. https://doi.org/10.3346/jkms.1997.12.3.256
  7. Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. Th e prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today 1992;22:421-425. https://doi.org/10.1007/BF00308791
  8. van Velthuysen ML, Taal BG, van der Hoeven JJ, Peterse JL. Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma. Histopathology 2005;46:153-157. https://doi.org/10.1111/j.1365-2559.2005.02062.x
  9. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fl uid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989;20:281-287. https://doi.org/10.1016/0046-8177(89)90137-8
  10. Mazoujian G, Pinkus GS, Davis S, Haagensen DE Jr. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 1983;110:105-112.
  11. Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin vs GCDFP- 15: an immunohistologic validation survey for sensitivity and specifi city. Am J Clin Pathol 2007;127:103-113. https://doi.org/10.1309/TDP92PQLDE2HLEET
  12. O'Connell FP, Wang HH, Odze RD. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005;129:338-347.
  13. Jones GE, Strauss DC, Forshaw MJ, Deere H, Mahedeva U, Mason RC. Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature. World J Surg Oncol 2007;5:75. https://doi.org/10.1186/1477-7819-5-75
  14. Miller WR, Larionov A. Molecular eff ects of oestrogen deprivation in breast cancer. Mol Cell Endocrinol 2011;340:127-136. https://doi.org/10.1016/j.mce.2011.04.020
  15. Challis GB, Stam HJ. Th e spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 1990;29:545- 550. https://doi.org/10.3109/02841869009090048